Prevention Works

• 15 minutes

Grants amounting to €650,000 have been awarded to European projects since 2007 under an annual programme to encourage applied research into the circovirus PCV2 and the disease pictures linked to it.  Decisions on pig health care have changed significantly in Europe over the past decade, regarding the use of vaccination in controlling the diseases associated with the virus known as PCV2. It is an extraordinary story of success that continues to expand as applied research and practical experience give even better insights into the virus itself and the diseases associated with it.

• 10 minutes

Ingelheim, Germany, 15 March 2016 –

For the third time, Boehringer Ingelheim Animal Health sponsors the European PRRS Research Award to support applied research for improved control of the swine disease PRRS (Porcine Reproductive and Respiratory Syndrome). Research proposals for the 2016 European PRRS Research Award can be submitted until July 1st, 2016. Boehringer Ingelheim Animal Health will provide three grants of 25,000 euros each to fund research proposals that will generate new and relevant data to better understand this devastating and costly disease.

• 10 minutes

For the ninth time, Boehringer Ingelheim Animal Health has funded independent European research projects related to Porcine Circovirus Type 2 (PCV2) infection and associated diseases. Over the past nine years, 26 research projects have been awarded with € 25,000 each accumulating to € 650,000 in total.

• 5 minutes

Protecting your herd against porcine reproductive and respiratory syndrome (PRRS) just became more convenient. In an effort to give producers and veterinarians a broader choice of sizes, Boehringer Ingelheim Vetmedica, Inc. (BIVI) now offers a 250-dose option for Ingelvac PRRS® MLV.